[Department of Error] Department of Error

Colombel J-F, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet 2017; published online Oct 31. http://dx.doi.org/10.1016/S0140-6736(17)32641-7. In figure 3B of this Article, the percentage of patients with an endoscopic response in the tight control group should have been 50 ·8%. In figure 4 of this Article, at randomisation, the number of patients in the tight control group who received adalimumab every other week should have been 79.
Source: LANCET - Category: General Medicine Tags: Department of Error Source Type: research